Profile
Ulrik Spork is currently the Chairman of the Board at Reapplix A, Chairman at Syddansk Innovation A, Chairman of the Board at Dansk Vækstkapital II K, Director at Neurescue ApS, and Director at InnoCon Medical ApS.
Previously, he served as Chairman at Practio ApS, Director at Corus Pharma, Inc., Light Sciences Oncology, Inc., Archimedes Pharma Ltd., and Celltrix AB.
He was also the Managing Partner at Novo Holdings AS (Denmark), Senior Partner at Novo Ventures 1 A, and Managing Partner at Novo Principal Investments.
Mr. Spork received his undergraduate and graduate degrees from the University of Copenhagen.
Ulrik Spork active positions
| Companies | Position | Start |
|---|---|---|
Neurescue ApS
 Neurescue ApS Medical SpecialtiesHealth Technology Neurescue ApS develops innovative medical devices for the treatment of cardiac arrest. It offers new platform of treatment methods for paramedics, nurses and doctors alike. The company was founded by Habib Frost in 2013 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Syddansk Innovation A/S
 Syddansk Innovation A/S Investment ManagersFinance Syddansk Innovation A/S (SDI) is a Danish venture capital firm funded by the Government of Denmark. The firm was established in 1998 by joining the two innovation environments Teknologisk Innovation A/S and Syddansk Innovation A/S, and is headquartered in Odense, Denmark. | Chairman | 20/04/2017 |
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Chairman | - |
InnoCon Medical ApS
 InnoCon Medical ApS Medical SpecialtiesHealth Technology InnoCon Medical is a privately owned Danish medical device company that was founded in 2017. The company is based in Aalborg, Denmark. InnoCon Medical develops a neuromodulation healthcare solution for people with incontinence. Jesper Nielsen has been the CEO of the company since 2017. | Director/Board Member | 01/10/2019 |
Dansk Vækstkapital II K/S
 Dansk Vækstkapital II K/S Investment ManagersFinance Dansk Vækstkapital II K/S is a fund of funds targeting unlisted private equity and venture funds in Scandinavia. It invest in funds with a minimum size of DKK 400 million to DKK 500 million. The fund focuses on venture and equity funds that invest in companies with up to 1000 employees and DKK 1,25 million in revenue. | Chairman | 01/01/2016 |
Former positions of Ulrik Spork
| Companies | Position | End |
|---|---|---|
Practio ApS
 Practio ApS Medical/Nursing ServicesHealth Services Practio ApS offers vaccination and medical consultancy services. It's offerings include vaccines for Yellow fever, Rabies, Typhoid, Hepatitis A and B, Meningitis, Cholera, and Measles, mumps, and rubella. The company was founded on September 29, 2014 and is headquartered in Copenhagen, Denmark. | Chairman | 20/12/2022 |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | President | 31/05/2014 |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Chief Investment Officer | 31/12/2008 |
Archimedes Pharma Ltd.
 Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
| ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Ulrik Spork
| University of Copenhagen | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
Light Sciences Oncology, Inc.
 Light Sciences Oncology, Inc. Pharmaceuticals: MajorHealth Technology Light Sciences Oncology, Inc. operates as a pharmaceutical company. It develops Aptocine for the treatment of solid tumors as well as other indications such as benign prostatic hyperplasia. The company was founded in 1994 and is headquartered in Bellevue, WA. | Health Technology |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Finance |
Archimedes Pharma Ltd.
Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Celltrix AB
 Celltrix AB Medical SpecialtiesHealth Technology Celltrix AB manufactures medical devices. It develops novel and injectable dermal filler for reconstructive cosmetic surgery, based on microbeads of cross-linked gelatine. The company was founded in December 2003 by Kjell Gösta Conny Nilsson and is headquartered in Malmö, Sweden. | Health Technology |
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Finance |
Novo Principal Investments
Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Finance |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Distribution Services |
Syddansk Innovation A/S
Syddansk Innovation A/S Investment ManagersFinance Syddansk Innovation A/S (SDI) is a Danish venture capital firm funded by the Government of Denmark. The firm was established in 1998 by joining the two innovation environments Teknologisk Innovation A/S and Syddansk Innovation A/S, and is headquartered in Odense, Denmark. | Finance |
Neurescue ApS
Neurescue ApS Medical SpecialtiesHealth Technology Neurescue ApS develops innovative medical devices for the treatment of cardiac arrest. It offers new platform of treatment methods for paramedics, nurses and doctors alike. The company was founded by Habib Frost in 2013 and is headquartered in Copenhagen, Denmark. | Health Technology |
Dansk Vækstkapital II K/S
Dansk Vækstkapital II K/S Investment ManagersFinance Dansk Vækstkapital II K/S is a fund of funds targeting unlisted private equity and venture funds in Scandinavia. It invest in funds with a minimum size of DKK 400 million to DKK 500 million. The fund focuses on venture and equity funds that invest in companies with up to 1000 employees and DKK 1,25 million in revenue. | Finance |
InnoCon Medical ApS
InnoCon Medical ApS Medical SpecialtiesHealth Technology InnoCon Medical is a privately owned Danish medical device company that was founded in 2017. The company is based in Aalborg, Denmark. InnoCon Medical develops a neuromodulation healthcare solution for people with incontinence. Jesper Nielsen has been the CEO of the company since 2017. | Health Technology |
Practio ApS
Practio ApS Medical/Nursing ServicesHealth Services Practio ApS offers vaccination and medical consultancy services. It's offerings include vaccines for Yellow fever, Rabies, Typhoid, Hepatitis A and B, Meningitis, Cholera, and Measles, mumps, and rubella. The company was founded on September 29, 2014 and is headquartered in Copenhagen, Denmark. | Health Services |
- Stock Market
- Insiders
- Ulrik Spork
